Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and OutcomeElisa Moser, Ayako Ura, Loreen Vogel, et al.
Gut|November 4, 2020
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinomaRunze Shang, Xinhua Song, Pan Wang, et al.
Hepatology (Baltimore, Md.)|February 10, 2019
Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in MiceYu Qiao, Jingxiao Wang, Eylul Karagoz, et al.
Cell Death & Disease|February 12, 2019
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironmentPan Wang, Xinhua Song, Kirsten Utpatel, et al.
Gastroenterology|December 15, 2010
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinomaDiego F Calvisi, Chunmei Wang, Coral Ho, et al.
The American Journal of Pathology|November 7, 2017
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell CarcinomaRosemarie Krupar, Matthias G Hautmann, Ravi R Pathak, et al.
Hepatology (Baltimore, Md.)|February 25, 2025
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humansWeiting Liao, Yi Zhang, Jingxiao Wang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2011
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II studyDietmar Ofner, Alexander F Devries, Renate Schaberl-Moser, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2015
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascadeChunmei Wang, Li Che, Junjie Hu, et al.
Pageof 27